You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 1
  • P03.03 Novel machine-learning tools improve cost-effective development of personalised immunotherapies: lowering false positive rates in the search for actionable immunogenic neoantigens

Article info

Article menu

Download PDFPDF

Poster Presentations
P03 Vaccine Therapy
P03.03 Novel machine-learning tools improve cost-effective development of personalised immunotherapies: lowering false positive rates in the search for actionable immunogenic neoantigens
Free

Authors

Citation

Bogaert C, Van Oudenhove L, Pfitzer L, et al
P03.03 Novel machine-learning tools improve cost-effective development of personalised immunotherapies: lowering false positive rates in the search for actionable immunogenic neoantigens
Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-ITOC8.26

Publication history

  • First published October 6, 2021.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.